TML-6 is an orally available curcumin derivative that inhibits synthesis of beta-amyloid (Abeta) and Abeta precursor protein, upregulates Apo E, activates Nrf2, suppresses NF-kappaB and mTOR, and ameliorates inflammation. It is suitable for Alzheimers disease research.
Molekulargewicht:
523.62
Reinheit:
99.71%
CAS Nummer:
[1462868-88-7]
Formel:
C30H37NO7
Target-Kategorie:
Nrf2|||mTOR|||NF-kappaB|||Beta Amyloid|||Others
T37148
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten